Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder

M A Jenike; L Baer; L Buttolph

Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder

J Clin Psychiatry. 1991 Jan;52(1):13-4.

Authors

M A Jenike¹, L Baer, L Buttolph

Affiliation

¹ Harvard Medical School, Boston, Mass.

PMID: 1988411

Abstract

Twenty patients with obsessive compulsive disorder were treated openly with fluoxetine for 20 weeks. In 10 of the patients, addition of buspirone during the last 8 weeks improved clinical response. The role of augmenting strategies is discussed.

Publication types

Clinical Trial

MeSH terms

Buspirone / therapeutic use*
Drug Therapy, Combination
Fluoxetine / therapeutic use*
Humans
Obsessive-Compulsive Disorder / drug therapy*
Obsessive-Compulsive Disorder / psychology
Pilot Projects
Prospective Studies
Psychiatric Status Rating Scales

Substances

Fluoxetine
Buspirone